Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV)

Avivagen Announces Recurring Order for OxC-betaTM Livestock

Business Wire May 3, 2021

Avivagen Announces First Purchase Order from Large Integrated Producer in Asia

Business Wire April 26, 2021

Avivagen Announces Largest Single Customer Purchase Order

Business Wire April 23, 2021

Avivagen Inc. to Issue Shares to Holders of Debentures in Lieu of Annual Maintenance Fee

Business Wire April 9, 2021

Avivagen Announces Results From Its Annual General Meeting April 8, 2021

Business Wire April 8, 2021

Avivagen Inc. to Issue Shares to Holders of Debentures in Lieu of Annual Maintenance Fee

Business Wire March 23, 2021

Avivagen Inc. Announces TSX Venture Exchange Approval for Extension of Warrants

Business Wire March 18, 2021

Avivagen Inc. Announces Stock Option Grants

Business Wire March 8, 2021

Avivagen Inc. Announces Proposed Extension of Warrants

Business Wire March 5, 2021

Avivagen Announces Upcoming Research Publication Highlighting The Benefits Of OxC-betaTM Livestock for Broiler Poultry

Business Wire March 4, 2021

Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2021

Business Wire March 3, 2021

Avivagen Selects Meyenberg International Group to Spearhead Expansion Efforts in Central and South America

Business Wire February 24, 2021

Avivagen Announces the Publication of its New Zealand OxC-beta(TM) Livestock Dairy Trial for Use Against Sub-Clinical Mastitis

Business Wire February 18, 2021

Avivagen Inc. Announces Closing of $7.5 Million Bought Deal Unit Offering

Business Wire February 16, 2021

Avivagen Inc. Announces Filing of Final Short Form Prospectus for Previously Announced $7.5 Million Bought Deal Unit Offering

Business Wire February 9, 2021

Avivagen Inc. Announces Filing of Preliminary Prospectus for Previously Announced $7.5 Million Bought Deal Unit Offering

Business Wire February 1, 2021

Mimi's Rock Corp. and Avivagen Announce Launch of Dr. Tobias Beta Blend on Amazon.com

Business Wire February 1, 2021

IIROC Trading Resumption - VIV

Canada NewsWire January 27, 2021

Avivagen Inc. Announces Upsize to Previously Announced Bought Deal Unit Offering

Business Wire January 27, 2021

 Avivagen Inc. Announces $5 Million Bought Deal Unit Offering

Business Wire January 26, 2021